Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Eurolide 3.75mg Depot Injection

Prescription Icon
Prescription Required

Marketer

Samarth Life Sciences Pvt Ltd

Salt Composition

Leuprolide (3.75mg)

Overview Eurolide 3.75mg Depot Injection

Goserelin 3.75mg Depot Injection is indicated for managing prostate cancer. It's also employed in the treatment of endometriosis (excessive uterine lining growth causing pain, heavy or irregular menstruation), uterine fibroids, and central precocious puberty (premature sexual development). Administration is via subcutaneous injection by a healthcare professional. Dosage and frequency are determined by your physician, varying based on your condition and potentially adjusted over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose may result in severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Frequently reported side effects include reduced libido, increased perspiration, tiredness, muscle weakness, and hot flushes. Prolonged use may lead to bone thinning and reduced bone density; calcium and vitamin D supplementation is recommended. Amenorrhea (absence of menstruation) for 7-12 weeks is possible; persistent bleeding requires medical attention. Prior to treatment, disclose any history of alcohol consumption, smoking, or osteoporosis to your doctor. Interactions with other medications are possible; inform your healthcare provider of all concurrent medications. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout the treatment period.

Primary Ingredients of Eurolide 3.75mg Depot Injection

The provided text is "undefined," so no rephrasing is possible.

Uses of Eurolide 3.75mg Depot Injection

Management of prostate carcinoma | Endometriosis care | Uterine fibroid management | Treatment of precocious puberty

Major Benefits of Eurolide 3.75mg Depot Injection:

This medication will be administered by your healthcare provider. Self-medication is not permitted.

Common Side effects of Eurolide 3.75mg Depot Injection:

  • Decreased libido
  • Testicular atrophy
  • Increased sweating
  • Fatigue
  • Muscle weakness
  • Erectile dysfunction
  • Hot flashes

How to use Eurolide 3.75mg Depot Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

How Eurolide 3.75mg Depot Injection works:

The injectable medication Eurolide 3.75mg Depot diminishes circulating sex hormones—testosterone in men and estrogen in women. Its mechanism involves lowering testosterone concentrations in the male bloodstream. In women, Eurolide 3.75mg Depot suppresses ovarian hormone production, resulting in reduced estrogen levels and subsequently, decreased menstrual activity.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using alcohol concurrently with Eurolide 3.75mg Depot Injection. Seek medical advice.

PregnancyPregnancyUNSAFE

Administration of Eurolide 3.75mg Depot Injection is contraindicated during pregnancy due to substantial risks. Pregnant women should consult their physician; research in animal and human subjects has demonstrated significant adverse effects on fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Eurolide 3.75mg Depot Injection with breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

The administration of Eurolide 3.75mg Depot Injection may induce adverse reactions that impair driving capabilities. Refrain from driving or operating machinery if you experience somnolence, vertigo, or visual abnormalities during your Eurolide 3.75mg Depot Injection treatment.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding the use of Eurolide 3.75mg Depot Injection in individuals with renal impairment is scarce. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the administration of Eurolide 3.75mg Depot Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Eurolide 3.75mg Depot Injection :

Omit a Eurolide 3.75mg Depot Injection? Seek your physician's advice.

Facts to Know About Eurolide 3.75mg Depot Injection

LabelValue
Chemical Classification GnRH Agonist
Developing Habits No.
Treatment Category Obstetrics and Gynecology

FAQs on Eurolide 3.75mg Depot Injection

Eurolide 3.75mg Depot Injection is not a chemotherapy drug but a synthetic hormone analogue used to treat hormone-dependent conditions in both men and women.
Eurolide 3.75mg Depot Injection may disrupt menstrual periods due to its effects on reproductive hormones. Some users experience irregular vaginal bleeding. Consult your doctor if this happens for evaluation and guidance.
Eurolide 3.75mg Depot Injection is a hormonal medication affecting female reproductive hormones. Its use is contraindicated in pregnant or potentially pregnant women due to the risk of fetal harm and potential miscarriage. Inform your doctor of your pregnancy status or pregnancy plans before commencing treatment.
Eurolide 3.75mg Depot Injection can weaken bones by reducing bone mineral density. Women should have bone density checked before treatment, especially those at high risk of osteoporosis. Additional medication to prevent osteoporosis may be necessary for patients with low bone mineral density.
Eurolide 3.75mg Depot Injection can raise blood sugar levels, potentially worsening diabetes control and increasing the risk of developing diabetes. Regular monitoring of blood glucose and/or HbA1c is crucial. Report any problems to your doctor. Diabetic patients should monitor their sugar levels more often while using this medication.
Eurolide 3.75mg Depot Inj...
1,875
MRP 2,176
13% off